METHODS FOR INCREASING LEVEL OF 2'-DEOXYURIDINE (DURD) IN PLASMA AND INHIBITING THYMIDYLATE SYNTHASE Russian patent published in 2022 - IPC A61K39/395 A61K31/4745 A61K31/513 A61K31/555 A61K45/06 A61P35/00 

Abstract RU 2775781 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to a method for increasing levels of 2’-deoxyuridine (hereinafter – dUrd) in plasma of a human subject. The method for increasing the concentration of 2’-deoxyuridine (dUrd) in plasma of a human subject includes: a stage (a) of injection of 400 mg/m2 or 500 mg/m2 of 5-fluorouracil (hereinafter – 5-FU) intravenously in the form of a bolus injection to a human subject; after the stage (a), a stage (b) of intravenous injection of 30, 60, 120 or 240 mg/m2 of [6R]-5,10-methylenetetrahydrofolate (hereinafter – 6R-MTHF) intravenously in the form of two bolus injections to the specified human subject, and (c) optional injection of 2400 mg/m2 of 5-FU in the form of continuous infusion simultaneously with the stage (b) or after it.

EFFECT: above-described method allows for significantly increasing dUrd in blood plasma in a joint injection of an equimolar dose of 6R-MTHF with 5-FU compared to a drug.

11 cl, 4 dwg, 2 tbl, 2 ex

Similar patents RU2775781C2

Title Year Author Number
ADMINISTRATION OF MULTIPLE BOLUSES [6R]-MTHF IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL 2018
  • Lindberg Per Lennart
  • Sunden Gunnel Elisabeth
  • Gustavsson Bengt
  • Vedin Anders
RU2762596C2
[6R]-MTHF-EFFECTIVE FOLATE ALTERNATIVE IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL 2018
  • Lindberg Per Lennart
  • Sunden Gunnel Elisabeth
  • Gustavsson Bengt
  • Vedin Anders
RU2763934C2
METHODS FOR TREATMENT OF COLORECTAL AND METASTATIC COLORECTAL CANCER 2019
  • Ganlov, Karin
  • Ostberg, Magnus
  • Lindberg, Per, L.
  • Sunden, Gunnel, E.
  • Gustavsson, Bengt
RU2779535C2
STABLE PHARMACEUTICAL COMPOSITION OF 5,10-METHYLENTETRAHYDROFOLATE 2004
  • Mozer Rudol'F
  • Ammann Tomas
RU2343923C2
REDUCTION METHOD FOR GASTROINTESTINAL TOXICITY CAUSED BY TEGAFUR 2005
  • Nomura Naruo
  • Takhara Takesi
  • Ambe Khirosi
  • Kuritani Dzun
RU2348409C2
THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE 2005
  • Shtajnfel'D Khajdi Mari
  • Borittski Teodor Dzhejms
  • Kalvert Alan Khilari
  • Kertin Nikola Dzhejn
  • Devzhi Mokhamed Raza
  • Khostomski Zdenek
  • Dzhounz Kristofer
  • Kaufman Ronda
  • Klehmerus Karen Dzh.
  • N'Juehll Dehvid Richard
  • Plammer Ehlizabet Rut
  • Rajkh Stiven Dehvid
  • Strehtford Ian Dzh.
  • Tomas Kh'Ju Dehvid
  • Uill'Jams Kaje Dzhanin
RU2361592C2
ANTIBODIES TO FGFR2 IN COMBINATION WITH CHEMOTHERAPY IN CANCER TREATMENT 2018
  • Collins, Helen L.
  • Hnatyszyn, James
  • Xiang, Hong
  • Zhang, Xiang
RU2797560C2
IL-6 RECEPTOR ANTIBODY FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS 2020
  • Baret-Cormel, Lydie
  • Momtahen, Tanya
  • Fiore, Stefano
  • Van Adelsberg, Janet
RU2822089C2
METHOD OF TREATING PATIENTS WITH CANCER WITH SEVERE RENAL INSUFFICIENCY 2017
  • Yoshida, Kenichiro
RU2727598C2
PHOSPHORUS AMIDATE DERIVATIVES OF 5-FLUORO-2'-DEOXYURIDINE APPLICABLE FOR TREATING CANCER 2012
  • Makgigan Kristofer
  • Balzarini Yan
  • Slusarzhik Magdalena
  • Gonzhi Blanka
  • Murziani Paola
RU2614406C2

RU 2 775 781 C2

Authors

Carlsson, Goran, U.

Gustavsson, Bengt

Odin, Elisabeth

Wettergren, Yvonne

Vedin, Anders

Dates

2022-07-11Published

2018-02-09Filed